A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

Local Institution - 0040, Wollongong

Local Institution - 0012, Ballarat Central

Local Institution - 0022, Murdoch

Local Institution - 0039, Mons

Local Institution - 0036, Roeselare

Local Institution - 0026, Santiago de Compostela

Local Institution - 0018, Madrid

Local Institution - 0011, Charlotte

Local Institution - 0019, Majadahonda (Madrid)

Local Institution - 0020, Málaga

Local Institution - 0001, Marietta

Local Institution - 0031, Seville

Local Institution - 0002, Kansas City

Local Institution - 0017, Rouen

Local Institution - 0035, Lone Tree

Local Institution - 0014, Toulon

Local Institution - 0015, Suresnes

Local Institution - 0038, Villejuif

Local Institution - 0028, Providencia

Local Institution - 0023, Santiago

Local Institution - 0030, Independencia

Local Institution - 0027, Recoleta

Local Institution - 0007, Orange

Local Institution - 0043, Clermont

Local Institution - 0010, Orange City

Local Institution - 0005, Louisville

Local Institution - 0044, Silver Spring

Henry Ford Hospital, Detroit

Local Institution - 0034, Arlington

Local Institution - 0045, Flower Mound

Local Institution - 0033, Fairfax

Local Institution - 0025, Barcelona

Local Institution - 0021, Barcelona